Brain cancer

During the active and treatment phase, medical records confirming a malignant brain tumor diagnosis and documenting ongoing or recently completed surgery, chemotherapy, radiation, or other treatment support the 100% rating. Records showing the date treatment ended are critical for tracking the 2-year continuation period. Once that period closes and VA evaluates neurological residuals, the evidence that matters shifts to what those residuals actually look like. Neuropsychological testing showing objective impairment in memory, attention, concentration, or executive functions is directly tied to the rating criteria. Examination findings on judgment, orientation, communication, motor activity, and visual-spatial skills are each measured separately. Records of neurobehavioral changes — such as irritability, impulsivity, or aggression — and notes about subjective symptoms like headaches, dizziness, or fatigue that affect your work or daily activities also connect to specific rating levels. Statements from you or people who know you describing how these symptoms affect work, relationships, and daily tasks can help show the degree of functional impairment at each level.